Zim Laboratories Limited

NSE: ZIMLAB · Unclassified

₹131.67-3.85%06 Nov 2026

Ask the data

Instant answers about Zim Laboratories Limited — computed from its filings, no language model

Market cap₹707 cr

Current price₹131.67

High / Low₹153 / ₹60

P/E341.3

P/B2.42

Book value₹54.5

ROE0.7%

ROCE3.9%

Debt / equity0.50

Dividend yield—

EPS (TTM)₹0.39

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY23	FY24	FY26
Revenue	398.5	367.4	374.4
EBITDA	52.0	41.3	30.0
Operating margin	13.0%	11.2%	8.0%
Interest	5.6	6.9	13.2
Depreciation	17.5	15.9	20.0
Profit before tax	35.4	23.6	8.2
Tax	10.9	6.4	2.4
Net profit	24.4	17.2	5.8
EPS ₹	5.01	3.54	1.19
Operating cash flow	37.5	16.3	49.5
Capex	36.7	73.9	44.4
Dividend paid	0.0	0.0	0.0
Total assets	341.6	446.8	539.4
Equity	200.3	238.8	296.1

Quarterly performance

last 15 quarters · ₹ crore

showing latest 8 of 15 periods

	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	101.0	105.4	67.4	85.8	96.3	117.9	81.8	92.1	96.3	71.8	88.7	108.7	105.3	94.2	105.5
Operating profit	13.1	15.4	4.8	9.3	11.5	15.7	8.0	9.5	11.6	4.3	5.8	12.8	7.2	2.5	5.4
Operating margin	13.0%	14.7%	7.2%	10.9%	12.0%	13.3%	9.8%	10.3%	12.0%	5.9%	6.5%	11.8%	6.8%	2.6%	5.1%
Other income	2.4	0.7	1.1	1.4	1.1	1.5	1.0	1.3	1.8	1.5	2.0	1.7	6.2	1.0	2.3
Interest	1.6	1.3	1.7	1.2	1.7	2.3	2.9	2.9	2.7	3.3	3.2	3.4	3.3	3.6	3.9
Depreciation	3.9	4.9	4.0	4.1	3.9	3.9	4.9	5.0	4.9	4.9	5.0	5.0	5.1	5.4	6.5
Profit before tax	10.0	9.9	0.2	5.4	7.0	11.0	1.2	3.0	5.7	-2.4	-0.3	6.0	4.9	-5.6	-2.7
Tax	3.4	2.7	-0.0	1.3	2.2	2.9	0.3	0.6	1.7	-0.6	0.1	1.6	1.2	-1.6	-0.7
Net profit	6.6	7.2	0.2	4.2	4.8	8.1	0.9	2.4	4.0	-1.9	-0.4	4.4	3.7	-4.0	-2.0
EPS ₹	1.35	1.48	0.05	0.85	0.98	1.66	0.18	0.49	0.82	-0.38	-0.09	0.90	0.76	-0.75	-0.38
Revenue YoY	—	—	—	—	-4.6%	11.8%	21.3%	7.4%	0.0%	-12.3%	-3.7%	12.8%	—	31.2%	18.9%
Profit YoY	—	—	—	—	-27.6%	11.7%	291.3%	-42.7%	-16.3%	-307.8%	-117.6%	10.0%	—	—	—

Earlier results (standalone, Dec '17 – Sep '22)

₹ crore · from BSE, before the NSE XBRL filings begin

Zim Laboratories Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

	FY19†	FY20†	FY21†	FY22†
Revenue	331.7	274.3	303.6	329.5
Operating profit	42.4	19.8	36.8	37.9
Operating margin	12.8%	7.2%	12.1%	11.5%
Other income	3.1	4.7	2.5	4.5
Interest	11.6	12.7	10.9	8.3
Depreciation	11.2	13.3	14.6	14.8
Profit before tax	22.7	-1.5	8.6	19.3
Tax	6.7	-3.2	3.0	6.3
Net profit	16.0	1.7	5.6	13.0

Quarters

showing latest 8 of 20 periods

	DEC '17†	MAR '18†	JUN '18†	SEP '18†	DEC '18†	MAR '19†	JUN '19†	SEP '19†	DEC '19†	MAR '20†	JUN '20†	SEP '20†	DEC '20†	MAR '21†	JUN '21†	SEP '21†	DEC '21†	MAR '22†	JUN '22†	SEP '22†
Revenue	75.1	70.6	69.9	71.1	97.0	93.6	66.9	67.3	72.2	67.9	69.8	86.5	74.2	73.2	63.6	75.7	86.0	104.1	92.5	99.3
Operating profit	10.9	8.3	7.7	10.0	12.4	12.3	2.7	4.4	6.9	5.8	9.7	11.2	7.4	8.5	4.9	8.7	10.6	13.7	11.4	12.1
Operating margin	14.5%	11.7%	11.0%	14.1%	12.8%	13.1%	4.1%	6.5%	9.5%	8.5%	13.9%	12.9%	10.0%	11.7%	7.7%	11.5%	12.4%	13.1%	12.3%	12.2%
Other income	0.3	1.6	1.4	0.2	0.7	0.8	1.1	0.4	0.7	2.5	0.6	0.2	0.8	0.8	1.2	0.9	0.7	1.6	1.9	1.4
Interest	1.5	2.9	3.7	3.0	2.5	2.5	3.2	3.2	3.2	3.0	2.9	2.7	2.3	2.9	2.5	2.6	1.8	1.4	1.3	1.4
Depreciation	2.5	2.6	2.6	2.9	2.8	3.0	3.1	3.2	3.5	3.6	3.5	3.5	3.6	3.9	3.4	4.1	3.5	3.9	4.0	4.0
Profit before tax	7.2	10.2	2.9	4.4	7.8	7.7	-2.5	-1.5	0.8	1.7	3.9	-0.1	2.2	2.5	0.3	2.9	6.1	10.0	8.0	8.2
Tax	0.9	3.2	0.2	1.4	2.2	3.0	-2.5	-1.0	0.1	0.2	1.1	0.0	0.7	1.2	0.1	0.9	1.7	3.6	2.3	2.5
Net profit	6.3	7.0	2.7	3.0	5.7	4.6	0.0	-0.5	0.7	1.5	2.8	-0.1	1.5	1.4	0.2	2.0	4.4	6.4	5.6	5.7
EPS ₹	7.79	8.60	3.33	1.89	3.51	2.87	0.02	-0.30	0.42	0.93	1.70	-0.03	0.94	0.85	0.11	1.24	2.70	3.96	3.47	3.49
Revenue YoY	—	—	—	—	29.3%	32.6%	-4.4%	-5.3%	-25.6%	-27.4%	4.4%	28.4%	2.8%	7.7%	-8.8%	-12.4%	15.9%	42.3%	45.3%	31.1%
Profit YoY	—	—	—	—	-10.0%	-33.5%	-98.9%	-116.1%	-87.8%	-67.3%	9133.3%	—	120.3%	-8.6%	-93.1%	—	188.8%	366.7%	2868.4%	183.0%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 9 periods

	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '26	JUN '26	SEP '26
ROE	8.1%	7.3%	7.2%	7.5%	6.7%	6.3%	2.0%	1.2%	0.7%
ROCE	11.0%	10.0%	8.9%	9.5%	9.4%	9.3%	5.1%	4.4%	3.9%
Net margin	5.1%	4.6%	4.7%	4.7%	4.2%	4.0%	1.6%	0.9%	0.5%
EBITDA margin	11.9%	11.6%	11.2%	11.7%	11.5%	11.5%	8.0%	7.1%	6.7%
Debt / equity	0.27	0.27	0.45	0.45	0.40	0.40	0.42	0.42	0.50
Interest coverage	5.38	4.81	4.41	4.06	3.28	2.94	1.62	1.38	1.19
Asset turnover	0.98	0.97	0.82	0.85	0.91	0.91	0.69	0.74	0.75

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 7 periods

	MAR '23	SEP '23	MAR '24	SEP '24	SEP '25	MAR '26	SEP '26
Share capital	48.7	48.7	48.7	48.7	48.7	53.5	53.7
Other equity / reserves	151.6	177.3	190.0	194.0	202.6	242.7	238.7
Total equity	200.3	226.0	238.8	242.8	251.3	296.1	292.4
Borrowings	59.6	60.1	106.3	97.3	117.3	123.0	146.2
Current liabilities	110.8	96.1	159.4	130.6	160.3	190.4	181.8
Non-current liabilities	30.4	43.6	48.6	54.0	58.5	52.8	73.7
Total assets	341.6	365.7	446.8	427.4	470.1	539.4	547.8
Property, plant & equipment	103.7	104.4	156.9	164.4	151.3	156.4	178.3
Capital work-in-progress	17.8	40.9	23.5	33.4	46.0	58.8	54.5
Investments	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Inventories	53.7	66.1	81.3	67.9	95.6	93.8	85.2
Receivables	95.2	68.4	100.2	81.6	102.1	109.0	101.4
Cash & equivalents	6.4	14.8	9.6	5.1	3.9	25.1	6.0

Cash flow

annual · ₹ crore · line = free cash flow

	FY23	FY24	FY26
Cash from operations	37.5	16.3	49.5
Cash from investing	-36.2	-73.0	-56.4
Cash from financing	0.6	59.5	28.2
Capex	36.7	73.9	44.4
Free cash flow	0.8	-57.6	5.2
Dividends paid	0.0	0.0	0.0

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹178.3 cr33%

CWIP

₹54.5 cr10%

Investments

₹0.1 cr0%

Inventories

₹85.2 cr16%

Receivables

₹101.4 cr19%

Cash & equivalents

₹6.0 cr1%

Other assets

₹122.3 cr22%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Zim Laboratories Limited	707	131.67	341.3	2.42	0.7%

StoxGud checklist: Neutral setup · 5/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-10.2%

6 months+39.1%

1 year+59.4%

3Y CAGR+2.3%

5Y CAGR—

10Y CAGR—

50-day avg₹135.36

200-day avg₹104.00

RSI (14)40

FAQs

What is the share price of Zim Laboratories Limited?

Zim Laboratories Limited (ZIMLAB) closed at ₹131.67 on NSE on 06 Nov 2026.

What is the market cap of Zim Laboratories Limited?

₹707 crore at the latest close.

What is the P/E ratio of Zim Laboratories Limited?

341.3, on trailing-twelve-month earnings from its filings.

How fast is Zim Laboratories Limited growing?

Zim Laboratories Limited: Latest-quarter revenue is up 18.9% year on year.

How profitable is Zim Laboratories Limited?

On a trailing-twelve-month basis return on equity is 0.7%, return on capital employed 3.9%, operating margin 6.7%, net margin 0.5%.

How much debt does Zim Laboratories Limited have?

Zim Laboratories Limited is lightly geared: debt to equity is 0.50 with borrowings of ₹146 cr against cash of ₹6 cr (balance sheet of 2026-09-30). Operating profit covers interest 1.2 times.

Financials parsed from Zim Laboratories Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from DEC '22, annual from FY23, balance sheet from Mar '23. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.